The International AIDS Vaccine Initiative has announced two grants totaling nearly $60 million from the Bill & Melinda Gates Foundation to expedite the development of AIDS vaccine candidates and other biomedical HIV prevention tools.
Over the next three and a half years, the funding will support expanded efforts through the Collaboration for AIDS Vaccine Discovery to expedite the development of a dozen promising AIDS vaccine candidates or biologics and advance them to the clinical testing stage.
"Accelerating the translation of innovative research into promising vaccine candidates for clinical testing is a real urgency," said Mark Feinberg, president and CEO of IAVI. "With more than two million people becoming infected with HIV in 2015 alone, there is no time to lose. Collaborative and efficient AIDS vaccine development today means more lives saved in the future."